Ether

Ether

SCHEMBL5144451

CCOCC.Cl.Cl.Cl.[Ti]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL11803367 0.95 ALDH1A1 (0.39)
Ether SCHEMBL87495 0.95
Ether SCHEMBL6583368 0.95
Ether SCHEMBL7116616 0.95
Ether SCHEMBL18045059 0.95
Ether SCHEMBL8322124 0.95 ALDH1A1 (0.44)
Ether SCHEMBL17390026 0.95 ALDH1A1 (0.44)
Ether SCHEMBL2877596 0.95
Ether SCHEMBL3620984 0.90
Ether SCHEMBL8772802 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299399-A4 CONVERSION OF COMPOUNDS OF TITANIUM IN A PLUS 4 OXIDATION STATE TO TITANIUM COMPOUNDS IN A PLUS 3 OXIDATION STATE BOULDER SCIENT CO (US) 2007-05-23 EP claimed
EP-1299399-A2 CONVERSION OF COMPOUNDS OF TITANIUM IN A PLUS 4 OXIDATION STATE TO TITANIUM COMPOUNDS IN A PLUS 3 OXIDATION STATE BOULDER SCIENTIFIC COMPANY (US) 2003-04-09 EP claimed
WO-2002066518-A2 CONVERSION OF TITANIUM COMPOUNDS IN THE +4 OXIDATION STATE T O TITANIUM COMPOUNDS IN THE +3 OXIDATION STATE BOULDER SCIENTIFIC COMPANY (US) 2002-08-29 WO claimed
US-6307063-B1 CONVERSION OF THE TI(III) PRODUCTS TO METALLOCENES BOULDER SCIENTIFIC COMPANY 2001-10-23 US claimed
US-4151337-A CATALYST COMPRISES ORGANOALUMINUM COMPOUND AND PRODUCT OF REACTING ETHER COMPLEXES OF VANADIUM AND TITANIUM TRICHLORIDE WITH HALIDE OF ALUMINUM AND/OR BORON MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1979-04-24 US claimed
US-4305920-A FOR POLYMERIZATION CATALYST MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1981-12-15 US disclosed
US-4151337-A CATALYST COMPRISES ORGANOALUMINUM COMPOUND AND PRODUCT OF REACTING ETHER COMPLEXES OF VANADIUM AND TITANIUM TRICHLORIDE WITH HALIDE OF ALUMINUM AND/OR BORON MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1979-04-24 US disclosed
US-4151337-A CATALYST COMPRISES ORGANOALUMINUM COMPOUND AND PRODUCT OF REACTING ETHER COMPLEXES OF VANADIUM AND TITANIUM TRICHLORIDE WITH HALIDE OF ALUMINUM AND/OR BORON MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1979-04-24 US disclosed
US-4115533-A REDUCING TITANIUM TETRACHLORIDE WITH AN ORGANIC ALUMINUM COMPOUND MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1978-09-19 US disclosed
US-4115532-A LEWIS ACIDS, HEATING, PRECIPITATION MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) 1978-09-19 US disclosed
US-4060593-A Preparation of titanium trichloride MITSUBISHI CHEMICAL INDUSTRIES (JA) 1977-11-29 US disclosed